Youtek is a team that develops and produces AI hardware products across the United States and China. Our mission is to enable more consumers to experience the efficiency and well-being brought by AI. ChatMaster is our brand for desktop interactive products and RiseWell is dedicated to health-focused office products.
YOUNGAND
YOUNGAND is a South Korean digital healthcare company focused on dementia prevention. We provide innovative solutions combining dual-task training and biometric data analysis to improve cognitive health, ensuring effective, accessible, and user-friendly brain health activities for seniors.
Yifan Motor
Founded in 1993: Based in Wuxi, China. IPO in 2021: Stock Code: 301023.SZ. Core Business: Gear motor, motor drive & controller. Industry Expert: Trusted gear motor supplier to Siemens, Schneider, ABB, Eaton, etc. Professional motion control supplier for high-end equipments, industrial automation, robotics, AMRs and AGVs.
Y-BRUSH
Y-Brush by Biotech Dental is an ideal oral care solution and is developed with input from our medical device range used in healthcare and patient care facilities.Y-Brush is designed to simplify the process of cleaning one’s teeth in just 20 seconds. This year, our spotlight will be on the “Y-Brush Halo”.
Xuxin (HongKong) Biotechnology Co., Limited
Xu Xin (Hong Kong) Biotechnology Co., Ltd. is a high-tech enterprise located in the Hong Kong Science Park, specializing in AI-driven research and development on innovative RNA-targeted therapy. The company is committed to addressing the unmet clinical needs in genetic diseases, neurological disorders, chronic diseases, and other therapeutic areas, and is dedicated to advancing the development of precision medicine through cutting-edge technologies. The company possesses a world-first RNA precision editing technology platform, which includes the world’s largest ADAR substrate editing library, an RNA fragment excising tool, and the AI-driven ATOMIC platform. These breakthrough innovations provide strong support and assurance for the company’s research and development of novel drugs. Through these top-notch technologies, the company is able to overcome the limitations of traditional small-molecule and biologic drugs, and to address key therapeutic challenges such as frameshift mutation diseases, single-point mutation genetic diseases, metabolic diseases and Immuno-oncology diseases. At the same time, our technical strategies ensure to avoid the irreversible off-target safety risks associated with DNA-level gene editing therapies.
XSTO CO., LTD.
XSTO leads in AI-powered all-terrain mobility robotics, offering smart travel and material-handling solutions. With strong R&D and core technologies like obstacle-crossing balance and AI control, we deliver safe, high-performance mobility for any terrain. | XSTO is a global leader in AI-powered all-terrain mobility robotics and a fully integrated provider of intelligent mobility equipment. The XSTO team is dedicated to transforming mobility and material handling, making travel and transport smarter and more efficient. Headquartered in Cuiheng New District, Zhongshan, Guangdong, XSTO has also established a technology R&D and marketing center in Guangzhou. Its business operations span over 80 countries and regions worldwide, providing efficient and reliable services to both enterprises and individual users. Through continuous investment in innovation and cutting-edge technologies, XSTO leads the industry’s development and technical standards, with market influence far exceeding that of its domestic and international peers. As a pioneer in the all-terrain mobility robot sector, XSTO has taken the lead in building two strategic systems: intelligent all-terrain travel and intelligent all-terrain material handling. With core technologies such as obstacle-crossing balance and AI control, XSTO delivers a superior level of safety and performance. It offers one-stop solutions for complex indoor and outdoor mobility and handling scenarios, aiming to create a smarter, safer, and more labor-saving future. | XSTO is a high-tech enterprise engaged in innovative material handling products and services, headquartered in Cuiheng New District, Zhongshan City, Guangdong Province, and has a R&D center and marketing department located in Guangzhou. Since the company was established, it is devoted to the R&D, manufacturing and sales of innovative material handling equipment. Over the past ten years, the company has continued to plough into the industry, continuous innovation, has applied for authorization of more than 110 patents including 7 PCT world invention patents, 22 invention patents and through the international quality certification system, the establishment of a number of industry and regional standards, the products are exported to more than 70 countries and regions. The market influence exceeds that of the international counterparts and has become the first ranked leader in the domestic segmentation of the leading enterprises.
XOLTAR
XOLTAR builds a lifelong, pharma-grade AI companion that delivers safe, emotionally intelligent support across health journeys including GLP-1, oncology, smoking cessation, stress, loneliness, and more. Combining evidence-based behavioral change with high engagement and strict safety, XOLTAR improves adherence and outcomes at scale.
Xiaomo Biotech Limited
Xiaomo Biotech is an expert on RNA biosynthesis. Our green biomanufacturing technology produces highly potent, specific, and cost-effective siRNAs (to kilograms) for various RNAi applications including gene knockdown in mammalian cells, high-throughput RNAi screen and RNAi pesticide. Xiaomo is committed to developing cutting-edge biotech products based on RNA interference (RNAi), a natural process which uses small interfering RNAs (siRNAs) to silence target genes in a precise manner. Xiaomo possesses a revolutionary RNAi platform technology known as the ‘prokaryotic siRNA’ (pro-siRNA) technology. The pro-siRNA technology uses bacteria as siRNA ‘factory’ instead of using chemical synthesis. This unique biomanufacturing method enables cost-effective and environmentally friendly production of highly effective siRNAs on a massive scale. Xiaomo has the capacity to produce siRNAs in gram to kilogram scales using bacterial fermentation. Xiaomo has also developed a customized high-throughput RNAi screen technique to identify potential therapeutic target genes in a disease, that could lead to the development of novel RNAi therapeutics. Currently, Xiaomo is offering various biomanufactured siRNA and RNAi library products to the R&D market. Xiaomo’s R&D efforts focus on developing first-in-class RNA pesticides for important crop pests including fungi, insects and nematodes. The ultimate goal of Xiaomo is to provide effective and affordable RNAi solutions for improving both human health and agricultural health. Xiaomo Biotech (www.xiaomobio.com) was founded at Hong Kong Science Park in 2019. We have recently established R&D and production sites in Shanghai Zhangjiang and Suzhou Kunshan China.